AngioDynamics ANGO Ratios & Valuation
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 54.3%-0.1pp | 54.6%+1.9pp | 54.1%+2.4pp | 53.9%+3.0pp | 54.4%+4.2pp | |
| Operating margin | -11.3%+5.8pp | -10.6%+72.7pp | -12.5%+69.7pp | -13.7%+49.7pp | -17.2%+44.2pp | |
| Net margin | -10%+4.6pp | -9%+69.4pp | -10.7%+72.3pp | -11.6%+49.0pp | -14.6%+44.8pp | |
| Returns | ||||||
| Return on equity | -17.5%+3.0pp | -15.3%+61.2pp | -17.1%+60.7pp | -17.5%+45.6pp | -20.5%+42.0pp | |
| Return on invested capital | -24.4%+8.9pp | -23.2%+75.8pp | -25.6%+66.6pp | -29.3%+44.1pp | -33.2%+43.7pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×+0.2× | 1.1×+0.4× | 1.1×+0.3× | 1×+0.3× | 0.9×+0.2× | |
| Liquidity | ||||||
| Current ratio | 2.4×+0.1× | 2.2×+0.3× | 2.3×0.0× | 2.2×+0.1× | 2.2×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0.1×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $4.17-8.4% | $4.24-7.0% | $4.34-10.2% | $4.48-12.5% | $4.55-16.3% | |
| Valuation | ||||||
| Market capitalization | $564.42M+38.7% | $510.88M+81.4% | $416.9M+38.8% | $394.29M+56.0% | $375.93M+71.8% | |
| Price / sales | 1.8×+0.4× | 1.7×+0.7× | 1.4×+0.4× | 1.3×+0.5× | 1.3×+0.7× | |
| Price / book | 3.3×+1.0× | 2.9×+1.4× | 2.3×+0.8× | 2.2×+0.9× | 2×+1.0× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are AngioDynamics's profit margins?
- AngioDynamics (ANGO) runs a 54.3% gross margin and a -11.3% operating margin, with a -10.0% net margin.
- Where do AngioDynamics's ratios come from?
- Every ratio is computed from AngioDynamics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
